• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP PULSESELECT; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP PULSESELECT; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH Back to Search Results
Model Number PSCC100
Device Problem Leak/Splash (1354)
Patient Problems Non specific EKG/ECG Changes (1817); Embolism/Embolus (4438); Heart Block (4444)
Event Date 02/29/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: product id 10fcc13; product type: sheath medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
It was reported that during pulsed field ablation procedure, st elevation and heart block were observed for twenty minutes after placing the pulsed field ablation catheter into the left atrium.It was suspected by the physician to be caused by an air bubble.The symptoms resolved after twenty minutes.No intervention was carried out. the case was completed with pulsed field ablation. no further patient complications have been reported as a result of this event.
 
Event Description
It was later reported that the patient experienced third degree heart block.It was surmised that the adverse events were caused by an air bubble; however, no air bubble was seen in the devices or the patient.
 
Manufacturer Narrative
Correction: updated imf code.Product event summary: the pscc100 pulsed field ablation catheter of lot number 0012123138 and data files containing two images were returned and analyzed.Both photos showed microbubbles were observed in the side port tube of the sheath.Visual inspection of the handle area was performed.Visual inspection was carried out on the catheter pscc100 of lot number 0012123138 and steerable sheath 10fcc13 of lot number 0012106995 appeared intact without any visible issues.Steering function was normal, with the distal catheter tip responding with approximately 170° rotation in both directions.Slide function is as expected, and the shape of the capture device is unremarkable with no atypical features.Mechanical verification of steering and slide mechanisms was carried out.The slide control function operated as expected without any issues.Upon full advancement of the slide control to extend the guidewire lumen, no kinking was observed along the extended portion, indicating proper functionality and alignment of the steering and slide mechanisms.The catheter to sheath connection evaluation was carried out.The catheter was smoothly introduced through the valve and threaded along the shaft of the sheath without encountering any resistance.Upon exiting the sheath tip, the array was deployed as anticipated, indicating proper functionality.Data from the catheter identification chip confirms usage on the reported event date.The catheter was reprogrammed before connection to the generator via the returned catheter interface cable (cic), and therapy deliveries were successfully performed.In conclusion, the reported st elevation and heart block issue that occurred during the procedure and could not be confirmed through product analysis or data analysis.A review of the data files showed microbubbles were observed in the side port tube of the sheath.The pulsed field ablation catheter passed the return product inspection.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSESELECT
Type of Device
PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
9000 autoroute transcanadienne
pointe-claire,qc H9R 5 Z8
CA  H9R 5Z8
Manufacturer (Section G)
MEDTRONIC CRYOCATH LP
9000 autoroute transcanadienne
pointe-claire,qc H9R 5 Z8
CA   H9R 5Z8
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18967619
MDR Text Key338471251
Report Number3002648230-2024-00107
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPSCC100
Device Catalogue NumberPSCC100
Device Lot Number0012123138
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/29/2024
Initial Date FDA Received03/25/2024
Supplement Dates Manufacturer Received05/07/2024
Supplement Dates FDA Received05/22/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-